SWM
KRRO icon

Spire Wealth Management’s Korro Bio KRRO Stock Holding History

Spire Wealth Management’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-39
Closed -$679 – 2482
2025
Q1 		$679 Hold
39
– – ﹤0.01% 2436
2024
Q4 		$1.49K Buy
+39
New +$2K ﹤0.01% 2305
2023
Q4 		– Sell
-39
Closed -$725 – 2421
2023
Q3 		$725 Hold
39
– – ﹤0.01% 2308
2023
Q2 		$678 Hold
39
– – ﹤0.01% 2352
2023
Q1 		$986 Buy
+39
New +$4.44K ﹤0.01% 2392

Other funds holding KRRO

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return

Spire Wealth Management's KRRO Position: Q2 2025 in Review

Spire Wealth Management sold out of Korro Bio (KRRO) in Q2 2025, closing a stake of 39 shares — an estimated $679 sold.

Spire Wealth Management first reported a position in KRRO in Q1 2023 and held it in 5 quarters. The position peaked at $1.49K in Q4 2024. 70 funds tracked by Wall St. Rank hold KRRO as of Q2 2025.

  • Spire Wealth Management reported no remaining Korro Bio position as of Q2 2025 after selling out during the quarter.
  • Spire Wealth Management sold 39 Korro Bio shares in Q2 2025, an estimated $679.
  • Spire Wealth Management first reported a position in Korro Bio in Q1 2023 and held it in 5 quarters.
  • Spire Wealth Management's Korro Bio position peaked at $1.49K in Q4 2024.
  • 70 funds tracked by Wall St. Rank held Korro Bio as of Q2 2025.

Based on Spire Wealth Management's 13F filing for Q2 2025, filed 4 Aug 2025.